Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.
Hani OweiraAnwar GiryesMeinrad MannhartMichael DeckerOmar Abdel-RahmanPublished in: Expert review of gastroenterology & hepatology (2018)
Time to start systemic chemotherapy does not appear to impact overall or progression-free survival among mCRC patients.